AlphaYou
Overview
Smart money at a glance
Filings to Oct 1, 2026No insider open-market trades in 90 days (SEC Form 4). Congress: both buying and selling, $4K to $60K in total in 180 days.
- Company insidersSEC Form 4, last 90 days
- $0No open-market trades
- CongressSTOCK Act, last 180 days
- $4K to $60K tradedMixed
- Big fundsSEC 13F, quarter ended Jun 30, 2026
- 11 added, 3 cutMore adding
Key stats
Fundamentals Sep 30- Open
- $71.40
- 52-wk high
- $145.99
- High
- $71.70
- 52-wk low
- $69.52
- Low
- $70.00
- Prev close
- $69.83
- Mkt cap
- $29.05B
- P/E
- 11.5x
- Volume
- 3.52M
- Fwd P/E
- 12.0x
- Beta
- 0.73
- Div yield
- 2.88%
- P/S
- 3.0x
- P/B
- 9.4x
- Profit margin
- +27.7%
- Op margin
- +40.7%
- ROE
- +64.9%
What do analysts expect?
Analyst target and ratings are on paid plans
See the 12-month consensus target and the buy/hold/sell rating split.
Unlock the full resultsQuestions about ZTS filings
Are insiders buying or selling Zoetis Inc (ZTS) stock?
Neither. Zoetis Inc (ZTS) insiders filed no open-market purchases or sales in the 90 days to Oct 1, 2026, according to SEC Form 4 filings.
Which members of Congress have traded ZTS recently?
Rep. Gilbert Cisneros (D) sold $1K to $15K on Jul 17, 2026, disclosed 49 days later. Rep. Gilbert Cisneros (D) bought $1K to $15K on Jun 16, 2026, disclosed 16 days later. Rep. Byron Donalds (R) bought $1K to $15K on Jun 9, 2026, disclosed 36 days later. Rep. Byron Donalds (R) bought $1K to $15K on Jun 9, 2026, disclosed 36 days later. In total, 2 members disclosed 4 ZTS trades with trade dates in the last 180 days, filed a median 36 days after trading.
How current is this ZTS smart-money data?
This summary uses filings available on Oct 1, 2026. Insiders must report trades to the SEC within 2 business days, members of Congress have up to 45 days to disclose a trade, and funds file 13F holdings up to 45 days after each quarter ends, so the latest moves may not be public yet.
Smart money
8 funds hold a position, insiders have been net buying, and 1 fin-fluencer is discussing it.
What funds are doing
Buys/Adds (2)
- CI
Citadel
$169.9M
added
- QR
Qube Research
$163.8M
bought
Sells/Trims (1)
- TS
Terry Smith
$458.4M
sold
What insiders are doing
Buys (3)
- DF
Damelio Frank A
$501K
bought
- BP
Bisaro Paul
$152K
bought
- MM
Mccallister Michael B
$233K
bought
What Congress is doing
Sells (1)
How top traders are positioned
No tracked top-trader positions in ZTS right now.
Live Hyperliquid positioning - not every stock is covered
Activist stakes, short interest & more
Earnings
Earnings came in 1.6% above what analysts expected.
Earnings per share
$1.84 expected
Revenue
$2.51B expected
GAAP EPS was $1.65 and adjusted EPS was $1.87. The adjusted figure is comparable to consensus.
Full Year 2026 guidance
$9.12B to $9.32B
No comparable estimate
Reports Nov 3, 2026, in 33 days
Estimates as of Oct 1, 2026
EPS expected
$1.46 to $1.60
Revenue expected
11 analysts
Last 30 days
Analysts cutting estimates
Estimate drift
Change in 30 days
What the company said
Financials
What it sold, what it cost, what was left.
| USD | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| What came in | ||||
| Revenue | $2.40B | $2.39B | $2.26B | $2.47B |
| Cost of what it sold | $715.0M | $743.0M | $641.0M | $673.0M |
| Gross profit | $1.69B | $1.64B | $1.62B | $1.79B |
| What it spent | ||||
| Research and development | $170.0M | $199.0M | $180.0M | $173.0M |
| Sales and admin | $579.0M | $619.0M | $588.0M | $592.0M |
| Other operating costs | — | — | $31.0M | $93.0M |
| Total operating expenses | $749.0M | $818.0M | $799.0M | $858.0M |
| What was left | ||||
| Operating profit | $936.0M | $826.0M | $822.0M | $937.0M |
| Interest on debt | $64.0M | $57.0M | $62.0M | $61.0M |
| Profit before tax | $887.0M | $761.0M | $758.0M | $866.0M |
| Tax | $166.0M | $158.0M | $157.0M | $175.0M |
| Net profit | $721.0M | $603.0M | $601.0M | $691.0M |
| EBITDA | $1.07B | $939.0M | $939.0M | $927.0M |
Technicals
Price structure
This stock is under pressure.
Trend
Under pressure
0 / 100
RSI 14
20D volatility
52-week range
20D support
20D resistance
Returns
Price vs moving averages
Volume pace
News
What the news says
Coverage leans bullish
What Is Drawing Attention To Axogen (AXGN)?
Leans bullishSep 28ABIVAX Société Anonyme (ENXTPA:ABVX) Following New Leadership Hires And Wider Losses Looks Undervalued
Leans bullishSep 28Absci Stock In Focus As Phase 2 Trial Plan Takes Shape
NeutralSep 27Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) Stock Has Consensus Price Target of $23.57 According to Brokerages
Leans bullishSep 25Veeco Instruments Inc. (NASDAQ:VECO) Stock Now Rated "Hold" by Wall Street Analysts
NeutralSep 25GAMCO Natural Resources, Gold & Income Trust Q2 2026 Commentary (GNT)
BearishSep 24Why Did Agilent Technologies (A) Shares Climb After Its Latest Update?
NeutralSep 23Andra AP fonden Buys 62,718 Shares of Ameriprise Financial, Inc. $AMP
NeutralSep 22
Macro
31 macro signals shaping ZTS right now
Unlock sector rotation, regime shifts, and macro event windows tied to this stock.
Unlock the full results